Sunlight Financial faces class-action suit alleging securities fraud in its financial woes

Sunlight Financial Holdings Inc. faces allegations of fraud and deceiving shareholders now that a federal judge has named a lead plaintiff and attorney for a class-action suit against the solar and home-improvements financing company.

Plans being shaped in Raleigh for potential high-rise development

NE Ohio serial entrepreneur wants to help wild bees with new company

From penthouses to mansions, here are Greater Boston’s biggest home sales in 2023 so far

Dallas-based private equity firm makes $200M bet on clinical research firm

PNC closing 11 more Northern Virginia branches — 10 in Giant Food stores

After rebranding, Cambridge biotech Astria licenses dermatitis drug for $320M

Migration Magnets: These counties are losing the most people in the New York City area

MyCrypto raises $4 million for ‘consumer-friendly gateway’ to cryptocurrency

Sunlight Financial faces class-action suit alleging securities fraud in its financial woes

Previous Elon Musk startups reveal plan to tie into Bastrop's water treatment system as neighbors air environmental grievances

Next Targeting the destruction of proteins, Peninsula biotech raises $50M

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Leasing momentum accelerates at New York City’s Paramount Building with 6 office leases

The Time’s Up movement comes to health care, with Mayo Clinic leading the charge

UAB Mary Heersink Institute for Global Health unveils cohort of pilot grant awardees

Housing Index: Still hard to find a house near Amazon HQ2, and prices are still climbing

Polis signs $38.5B budget for post-pandemic era

Efforts to unionize at Tiff’s Treats stores peter out

MENU

FirstStar Group

More Stories

Trying to treat most food allergies, drug developer Alladapt raises $119M